3 ASX growth shares to buy right now

Altium Limited (ASX:ALU) and these ASX growth shares could be ones to buy in January. Here's why they are rated highly…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

Are you looking to add a growth share or two to your portfolio? Then take a look at the three ASX shares listed below.

Here's why they could be growth shares to buy right now:

Altium Limited (ASX: ALU)

With the Altium share price down almost one-third from its 52-week high, it's no surprise to see brokers recommending it as a buy. Especially given the electronic design software provider's outstanding long term growth potential thanks to its exposure to the rapidly growing Internet of Things and AI markets. These are driving strong demand for its Altium Designer and Altium 365 software and also its other businesses such as Octopart. Morgan Stanley has an overweight rating and $40.00 price target on its shares.

Aristocrat Leisure Limited (ASX: ALL)

Another growth share to look at is Aristocrat Leisure. It is one of the world's leading gaming technology companies. Thanks to its industry-leading pokie machines and the huge potential of its digital and social gaming business, Aristocrat Leisure has been tipped to grow strongly over the 2020s. Especially once the pandemic passes and casinos around the world are open as normal again. Analysts at Citi recently put a buy rating and $40.60 price target on its shares.

ResMed Inc. (ASX: RMD)

A final growth share to look at is ResMed. It is a medical device company which has a focus on sleep treatment solutions. It also creates ventilators, which have been experiencing incredible demand because of the pandemic. Over the last decade the company's revenue and earnings have grown at a very strong rate thanks to the quality of its products and its large and growing market opportunity. In respect to the latter, management estimates that there are almost one billion people with sleep apnoea globally and a little under half a billion people that suffer from chronic obstructive pulmonary disease (COPD). Morgans has an add rating and $30.99 price target on ResMed's shares.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Altium. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

Three happy office workers cheer as they read about good financial news on a laptop.
Growth Shares

5 ASX growth shares to buy and hold

Analysts think these shares could be top picks for investors looking for growth options.

Read more »

Two players on a field pump their fists in the air, indicating two of the best
Growth Shares

The ultimate buy and hold ASX 200 shares for long-term investors

These buy-rated shares could be great options for investors with a long time horizon.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

3 unstoppable ASX shares to buy and hold for the next decade

These shares are going places over the remainder of the decade and beyond.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 high-growth ASX shares to buy today: brokers

These stocks have a strong growth outlook.

Read more »

Two university students in the library, one in a wheelchair, log in for the first time with the help of a lecturer.
Growth Shares

2 top-quality ASX shares to buy for beginner investors

These stocks could be a great place to start investing.

Read more »

A man in full American NFL playing kit crouches over with his arms across his chest in a defensive stance against a dark background.
Growth Shares

Here's why these two ASX 300 shares are great ones to own

These businesses are two of the fastest-growing stocks in the ASX 300 and are liked by fund manager WAM.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Growth Shares

3 ASX growth shares you'll wish you bought in June

Analysts think these shares could be destined for big things in the future.

Read more »

Father and daughter with hands on a small plant.
ETFs

Focused on growth? Here are 3 ASX ETFs to consider

Growth investors must ignore the current market noise about tariffs and focus on the long-term horizon.

Read more »